| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2023220 | Regulatory Peptides | 2008 | 12 Pages |
Abstract
These results show that the orally-active CCK-2R antagonist, Z-360 has high sub-nM affinity for classical CCK-2R, is well tolerated in vivo and exerts an anti-tumour effect.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
A.M. Grabowska, T.M. Morris, A.J. McKenzie, R. Kumari, H. Hamano, Y. Emori, K. Yoshinaga, S.A. Watson,